Gebauer Julie Jarecke 4

What Happened
Julie J. Gebauer, President — Health, Wealth & Career at Willis Towers Watson (WTW), received restricted share unit (RSU) awards on July 10, 2026. The filing reports two derivative awards: 65.403 RSUs at $289.65 each (value $18,944) and 2.24 RSUs at $289.65 each (value $649), totaling 67.643 RSUs valued at about $19,593. These are grants/awards (compensation), not open-market purchases or sales.

Key Details

• Transaction date: July 10, 2026. Grant code: A (award/grant). Price used: $289.65 per share. Combined value ≈ $19,593.
• Shares owned after transaction: Not reported in the Form 4 provided.
• Footnotes of note:
  • F1/F3: RSUs are derivative awards that settle 1:1 into ordinary shares under specified timing (e.g., six months after termination or other plan-specific settlement dates).
  • F2/F4: Portions include RSUs credited under the company’s non-qualified deferred savings and stable value excess plans (employee deferrals and company matching).
  • Nominal ordinary share par value reported as $0.000304635 per share (administrative detail).
• Filing timeliness: Form filed July 14, 2026 — within the standard two business-day window after the July 10 transaction (timely).

Context
These entries are compensatory RSU grants that will convert into ordinary WTW shares according to the plan terms and settlement timing noted in the footnotes. Because these are awards (not purchases), they reflect compensation or deferred-pay activity rather than a direct market signal of the insider buying or selling shares.